Philip I. Mccloud - Publications

In response to Bobelyak et al. (2025), Pocock and Chan (2025) and Chan et al. (2026).

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: April 27, 2026

Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study.

Journal: BMJ open respiratory research

Published: February 11, 2024

Living With Hereditary Angioedema in Australia: Findings From a National Observational Study Using Short Message Service to Monitor the Burden of Disease.

Journal: The journal of allergy and clinical immunology. In practice

Published: July 19, 2022

Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial.

Journal: Scientific reports

Published: February 28, 2022

Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.

Journal: NEJM evidence

Published: January 01, 2022

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis.

Journal: European journal of obstetrics & gynecology and reproductive biology: X

Published: September 30, 2020

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine.

Journal: Human vaccines & immunotherapeutics

Published: May 19, 2020

Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness-A Multisite Randomized Placebo Controlled Trial.

Journal: Journal of pain and symptom management

Published: August 11, 2019

Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.

Journal: European journal of obstetrics, gynecology, and reproductive biology

Published: August 05, 2019

A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.

Journal: PloS one

Published: July 15, 2019

Regular, sustained-release morphine for chronic breathlessness: a multicentre, double-blind, randomised, placebo-controlled trial.

Journal: Thorax

Published: June 05, 2019

A simple algorithm to predict non-compliance with organ at risk dose-volume constraints when planning intensity modulated post-prostatectomy radiation treatment: 'Why we should put the CART before the horse'.

Journal: Journal of medical imaging and radiation oncology

Published: September 27, 2018